Global and Japan Botulism Treatment Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Botulism Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Antitoxin
1.2.3 Antibiotics
1.2.4 Others
1.3 Market by Application
1.3.1 Global Botulism Treatment Market Share by Application: 2020 VS 2026
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Botulism Treatment Market Perspective (2015-2026)
2.2 Global Botulism Treatment Growth Trends by Regions
2.2.1 Botulism Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Botulism Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Botulism Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Botulism Treatment Players by Market Size
3.1.1 Global Top Botulism Treatment Players by Revenue (2015-2020)
3.1.2 Global Botulism Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Botulism Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Botulism Treatment Revenue
3.4 Global Botulism Treatment Market Concentration Ratio
3.4.1 Global Botulism Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Botulism Treatment Revenue in 2019
3.5 Key Players Botulism Treatment Area Served
3.6 Key Players Botulism Treatment Product Solution and Service
3.7 Date of Enter into Botulism Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Botulism Treatment Breakdown Data by Type (2015-2026)
4.1 Global Botulism Treatment Historic Market Size by Type (2015-2020)
4.2 Global Botulism Treatment Forecasted Market Size by Type (2021-2026)
5 Botulism Treatment Breakdown Data by Application (2015-2026)
5.1 Global Botulism Treatment Historic Market Size by Application (2015-2020)
5.2 Global Botulism Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Botulism Treatment Market Size (2015-2026)
6.2 North America Botulism Treatment Market Size by Type (2015-2020)
6.3 North America Botulism Treatment Market Size by Application (2015-2020)
6.4 North America Botulism Treatment Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Botulism Treatment Market Size (2015-2026)
7.2 Europe Botulism Treatment Market Size by Type (2015-2020)
7.3 Europe Botulism Treatment Market Size by Application (2015-2020)
7.4 Europe Botulism Treatment Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Botulism Treatment Market Size (2015-2026)
8.2 China Botulism Treatment Market Size by Type (2015-2020)
8.3 China Botulism Treatment Market Size by Application (2015-2020)
8.4 China Botulism Treatment Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Botulism Treatment Market Size (2015-2026)
9.2 Japan Botulism Treatment Market Size by Type (2015-2020)
9.3 Japan Botulism Treatment Market Size by Application (2015-2020)
9.4 Japan Botulism Treatment Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Botulism Treatment Market Size (2015-2026)
10.2 Southeast Asia Botulism Treatment Market Size by Type (2015-2020)
10.3 Southeast Asia Botulism Treatment Market Size by Application (2015-2020)
10.4 Southeast Asia Botulism Treatment Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 XOMA (U.S.)
11.1.1 XOMA (U.S.) Company Details
11.1.2 XOMA (U.S.) Business Overview
11.1.3 XOMA (U.S.) Botulism Treatment Introduction
11.1.4 XOMA (U.S.) Revenue in Botulism Treatment Business (2015-2020))
11.1.5 XOMA (U.S.) Recent Development
11.2 Microbiotix (U.S.)
11.2.1 Microbiotix (U.S.) Company Details
11.2.2 Microbiotix (U.S.) Business Overview
11.2.3 Microbiotix (U.S.) Botulism Treatment Introduction
11.2.4 Microbiotix (U.S.) Revenue in Botulism Treatment Business (2015-2020)
11.2.5 Microbiotix (U.S.) Recent Development
11.3 Valeant Pharmaceuticals (Canada)
11.3.1 Valeant Pharmaceuticals (Canada) Company Details
11.3.2 Valeant Pharmaceuticals (Canada) Business Overview
11.3.3 Valeant Pharmaceuticals (Canada) Botulism Treatment Introduction
11.3.4 Valeant Pharmaceuticals (Canada) Revenue in Botulism Treatment Business (2015-2020)
11.3.5 Valeant Pharmaceuticals (Canada) Recent Development
11.4 Morphotek (U.S.)
11.4.1 Morphotek (U.S.) Company Details
11.4.2 Morphotek (U.S.) Business Overview
11.4.3 Morphotek (U.S.) Botulism Treatment Introduction
11.4.4 Morphotek (U.S.) Revenue in Botulism Treatment Business (2015-2020)
11.4.5 Morphotek (U.S.) Recent Development
11.5 Medytox Solutions (U.S.)
11.5.1 Medytox Solutions (U.S.) Company Details
11.5.2 Medytox Solutions (U.S.) Business Overview
11.5.3 Medytox Solutions (U.S.) Botulism Treatment Introduction
11.5.4 Medytox Solutions (U.S.) Revenue in Botulism Treatment Business (2015-2020)
11.5.5 Medytox Solutions (U.S.) Recent Development
11.6 Lanzhou Institute of Biological Products (China)
11.6.1 Lanzhou Institute of Biological Products (China) Company Details
11.6.2 Lanzhou Institute of Biological Products (China) Business Overview
11.6.3 Lanzhou Institute of Biological Products (China) Botulism Treatment Introduction
11.6.4 Lanzhou Institute of Biological Products (China) Revenue in Botulism Treatment Business (2015-2020)
11.6.5 Lanzhou Institute of Biological Products (China) Recent Development
11.7 Mentor Corporation and Metabiologics (U.S.)
11.7.1 Mentor Corporation and Metabiologics (U.S.) Company Details
11.7.2 Mentor Corporation and Metabiologics (U.S.) Business Overview
11.7.3 Mentor Corporation and Metabiologics (U.S.) Botulism Treatment Introduction
11.7.4 Mentor Corporation and Metabiologics (U.S.) Revenue in Botulism Treatment Business (2015-2020)
11.7.5 Mentor Corporation and Metabiologics (U.S.) Recent Development
11.8 Merz Pharma (Germany)
11.8.1 Merz Pharma (Germany) Company Details
11.8.2 Merz Pharma (Germany) Business Overview
11.8.3 Merz Pharma (Germany) Botulism Treatment Introduction
11.8.4 Merz Pharma (Germany) Revenue in Botulism Treatment Business (2015-2020)
11.8.5 Merz Pharma (Germany) Recent Development
11.9 Allergan (Irish)
11.9.1 Allergan (Irish) Company Details
11.9.2 Allergan (Irish) Business Overview
11.9.3 Allergan (Irish) Botulism Treatment Introduction
11.9.4 Allergan (Irish) Revenue in Botulism Treatment Business (2015-2020)
11.9.5 Allergan (Irish) Recent Development
11.10 Galderma (Switzerland)
11.10.1 Galderma (Switzerland) Company Details
11.10.2 Galderma (Switzerland) Business Overview
11.10.3 Galderma (Switzerland) Botulism Treatment Introduction
11.10.4 Galderma (Switzerland) Revenue in Botulism Treatment Business (2015-2020)
11.10.5 Galderma (Switzerland) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Botulism Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Antitoxin
Table 4. Key Players of Antibiotics
Table 5. Key Players of Others
Table 6. Global Botulism Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Botulism Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Botulism Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Botulism Treatment Market Share by Regions (2015-2020)
Table 10. Global Botulism Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Botulism Treatment Market Share by Regions (2021-2026)
Table 12. Botulism Treatment Market Market Trends
Table 13. Botulism Treatment Market Drivers
Table 14. Botulism Treatment Market Challenges
Table 15. Botulism Treatment Market Restraints
Table 16. Global Botulism Treatment Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Botulism Treatment Market Share by Players (2015-2020)
Table 18. Global Top Botulism Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Botulism Treatment as of 2019)
Table 19. Global Botulism Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Botulism Treatment Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Botulism Treatment Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Botulism Treatment Market Size Share by Type (2015-2020)
Table 25. Global Botulism Treatment Revenue Market Share by Type (2021-2026)
Table 26. Global Botulism Treatment Market Size Share by Application (2015-2020)
Table 27. Global Botulism Treatment Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Botulism Treatment Market Size Share by Application (2021-2026)
Table 29. North America Botulism Treatment Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Botulism Treatment Market Share by Type (2015-2020)
Table 31. North America Botulism Treatment Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Botulism Treatment Market Share by Application (2015-2020)
Table 33. North America Botulism Treatment Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Botulism Treatment Market Share by Country (2015-2020)
Table 35. Europe Botulism Treatment Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Botulism Treatment Market Share by Type (2015-2020)
Table 37. Europe Botulism Treatment Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Botulism Treatment Market Share by Application (2015-2020)
Table 39. Europe Botulism Treatment Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Botulism Treatment Market Share by Country (2015-2020)
Table 41. China Botulism Treatment Market Size by Type (2015-2020) (US$ Million)
Table 42. China Botulism Treatment Market Share by Type (2015-2020)
Table 43. China Botulism Treatment Market Size by Application (2015-2020) (US$ Million)
Table 44. China Botulism Treatment Market Share by Application (2015-2020)
Table 45. China Botulism Treatment Market Size by Region (US$ Million) (2015-2020)
Table 46. China Botulism Treatment Market Share by Region (2015-2020)
Table 47. Japan Botulism Treatment Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Botulism Treatment Market Share by Type (2015-2020)
Table 49. Japan Botulism Treatment Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Botulism Treatment Market Share by Application (2015-2020)
Table 51. Japan Botulism Treatment Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Botulism Treatment Market Share by Country (2015-2020)
Table 53. Southeast Asia Botulism Treatment Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Botulism Treatment Market Share by Type (2015-2020)
Table 55. Southeast Asia Botulism Treatment Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Botulism Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Botulism Treatment Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Botulism Treatment Market Share by Country (2015-2020)
Table 59. XOMA (U.S.) Company Details
Table 60. XOMA (U.S.) Business Overview
Table 61. XOMA (U.S.) Product
Table 62. XOMA (U.S.) Revenue in Botulism Treatment Business (2015-2020) (US$ Million)
Table 63. XOMA (U.S.) Recent Development
Table 64. Microbiotix (U.S.) Company Details
Table 65. Microbiotix (U.S.) Business Overview
Table 66. Microbiotix (U.S.) Product
Table 67. Microbiotix (U.S.) Revenue in Botulism Treatment Business (2015-2020) (US$ Million)
Table 68. Microbiotix (U.S.) Recent Development
Table 69. Valeant Pharmaceuticals (Canada) Company Details
Table 70. Valeant Pharmaceuticals (Canada) Business Overview
Table 71. Valeant Pharmaceuticals (Canada) Product
Table 72. Valeant Pharmaceuticals (Canada) Revenue in Botulism Treatment Business (2015-2020) (US$ Million)
Table 73. Valeant Pharmaceuticals (Canada) Recent Development
Table 74. Morphotek (U.S.) Company Details
Table 75. Morphotek (U.S.) Business Overview
Table 76. Morphotek (U.S.) Product
Table 77. Morphotek (U.S.) Revenue in Botulism Treatment Business (2015-2020) (US$ Million)
Table 78. Morphotek (U.S.) Recent Development
Table 79. Medytox Solutions (U.S.) Company Details
Table 80. Medytox Solutions (U.S.) Business Overview
Table 81. Medytox Solutions (U.S.) Product
Table 82. Medytox Solutions (U.S.) Revenue in Botulism Treatment Business (2015-2020) (US$ Million)
Table 83. Medytox Solutions (U.S.) Recent Development
Table 84. Lanzhou Institute of Biological Products (China) Company Details
Table 85. Lanzhou Institute of Biological Products (China) Business Overview
Table 86. Lanzhou Institute of Biological Products (China) Product
Table 87. Lanzhou Institute of Biological Products (China) Revenue in Botulism Treatment Business (2015-2020) (US$ Million)
Table 88. Lanzhou Institute of Biological Products (China) Recent Development
Table 89. Mentor Corporation and Metabiologics (U.S.) Company Details
Table 90. Mentor Corporation and Metabiologics (U.S.) Business Overview
Table 91. Mentor Corporation and Metabiologics (U.S.) Product
Table 92. Mentor Corporation and Metabiologics (U.S.) Revenue in Botulism Treatment Business (2015-2020) (US$ Million)
Table 93. Mentor Corporation and Metabiologics (U.S.) Recent Development
Table 94. Merz Pharma (Germany) Business Overview
Table 95. Merz Pharma (Germany) Product
Table 96. Merz Pharma (Germany) Company Details
Table 97. Merz Pharma (Germany) Revenue in Botulism Treatment Business (2015-2020) (US$ Million)
Table 98. Merz Pharma (Germany) Recent Development
Table 99. Allergan (Irish) Company Details
Table 100. Allergan (Irish) Business Overview
Table 101. Allergan (Irish) Product
Table 102. Allergan (Irish) Revenue in Botulism Treatment Business (2015-2020) (US$ Million)
Table 103. Allergan (Irish) Recent Development
Table 104. Galderma (Switzerland) Company Details
Table 105. Galderma (Switzerland) Business Overview
Table 106. Galderma (Switzerland) Product
Table 107. Galderma (Switzerland) Revenue in Botulism Treatment Business (2015-2020) (US$ Million)
Table 108. Galderma (Switzerland) Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Botulism Treatment Market Share by Type: 2020 VS 2026
Figure 2. Antitoxin Features
Figure 3. Antibiotics Features
Figure 4. Others Features
Figure 5. Global Botulism Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals and Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Botulism Treatment Report Years Considered
Figure 9. Global Botulism Treatment Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Botulism Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Botulism Treatment Market Share by Regions (2021-2026)
Figure 12. Global Botulism Treatment Market Share by Players in 2019
Figure 13. Global Top Botulism Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Botulism Treatment as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Botulism Treatment Revenue in 2019
Figure 15. North America Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Rest of Europe Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa Botulism Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. XOMA (U.S.) Revenue Growth Rate in Botulism Treatment Business (2015-2020)
Figure 43. Microbiotix (U.S.) Revenue Growth Rate in Botulism Treatment Business (2015-2020)
Figure 44. Valeant Pharmaceuticals (Canada) Revenue Growth Rate in Botulism Treatment Business (2015-2020)
Figure 45. Morphotek (U.S.) Revenue Growth Rate in Botulism Treatment Business (2015-2020)
Figure 46. Medytox Solutions (U.S.) Revenue Growth Rate in Botulism Treatment Business (2015-2020)
Figure 47. Lanzhou Institute of Biological Products (China) Revenue Growth Rate in Botulism Treatment Business (2015-2020)
Figure 48. Mentor Corporation and Metabiologics (U.S.) Revenue Growth Rate in Botulism Treatment Business (2015-2020)
Figure 49. Merz Pharma (Germany) Revenue Growth Rate in Botulism Treatment Business (2015-2020)
Figure 50. Allergan (Irish) Revenue Growth Rate in Botulism Treatment Business (2015-2020)
Figure 51. Galderma (Switzerland) Revenue Growth Rate in Botulism Treatment Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed